DE69527400D1 - Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel - Google Patents
Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittelInfo
- Publication number
- DE69527400D1 DE69527400D1 DE69527400T DE69527400T DE69527400D1 DE 69527400 D1 DE69527400 D1 DE 69527400D1 DE 69527400 T DE69527400 T DE 69527400T DE 69527400 T DE69527400 T DE 69527400T DE 69527400 D1 DE69527400 D1 DE 69527400D1
- Authority
- DE
- Germany
- Prior art keywords
- production
- water
- camptothecin derivatives
- antitumor agent
- soluble camptothecin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9402934A GB9402934D0 (en) | 1994-02-16 | 1994-02-16 | Camptothecin derivatives and process for their preparation |
PCT/EP1995/000393 WO1995022549A1 (en) | 1994-02-16 | 1995-02-03 | Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69527400D1 true DE69527400D1 (de) | 2002-08-22 |
DE69527400T2 DE69527400T2 (de) | 2003-03-06 |
Family
ID=10750430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69527400T Expired - Fee Related DE69527400T2 (de) | 1994-02-16 | 1995-02-03 | Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel |
Country Status (20)
Country | Link |
---|---|
US (2) | US5602141A (de) |
EP (1) | EP0694035B1 (de) |
JP (1) | JPH08509244A (de) |
KR (1) | KR960701878A (de) |
CN (1) | CN1123548A (de) |
AT (1) | ATE220681T1 (de) |
AU (1) | AU681941B2 (de) |
CA (1) | CA2158855C (de) |
DE (1) | DE69527400T2 (de) |
ES (1) | ES2180625T3 (de) |
FI (1) | FI954898A0 (de) |
GB (1) | GB9402934D0 (de) |
HU (1) | HUT73423A (de) |
IL (1) | IL112622A (de) |
MX (1) | MX9504287A (de) |
NO (1) | NO954072L (de) |
NZ (1) | NZ279813A (de) |
PL (1) | PL311122A1 (de) |
WO (1) | WO1995022549A1 (de) |
ZA (1) | ZA951227B (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9319944D0 (en) * | 1993-09-28 | 1993-11-17 | Erba Carlo Spa | Process for the preparation of 9-amino camptothecin |
US5965566A (en) * | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
GB9410388D0 (en) * | 1994-05-24 | 1994-07-13 | Erba Carlo Spa | Method for the preparation of 9-amino camptothecin |
GB9510716D0 (en) * | 1995-05-26 | 1995-07-19 | Pharmacia Spa | Substituted camptothecin derivatives and process for their preparation |
US6096336A (en) * | 1996-01-30 | 2000-08-01 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
GB9601779D0 (en) * | 1996-01-30 | 1996-04-03 | Pharmacia Spa | 9, 10 Disubstituted camptothecin derivatives |
GB9702807D0 (en) | 1997-02-12 | 1997-04-02 | Pharmacia & Upjohn Spa | Alkynyl-substituted camptothecins and process for their preparation |
GB9715821D0 (en) * | 1997-07-25 | 1997-10-01 | Pharmacia & Upjohn Spa | Amidino-camptothecin derivatives |
US6043367A (en) * | 1998-09-30 | 2000-03-28 | Roffler; Steve | Proactive antitumor compounds |
US6228855B1 (en) | 1999-08-03 | 2001-05-08 | The Stehlin Foundation For Cancer Research | Aromatic esters of camptothecins and methods to treat cancers |
US6352996B1 (en) | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
EP1229934B1 (de) | 1999-10-01 | 2014-03-05 | Immunogen, Inc. | Zusammensetzungen und verfahren zur behandlung von krebs mittels immunkonjugaten und chemotherapeutischen agenzien |
IL162058A0 (en) | 2001-11-30 | 2005-11-20 | Chugai Pharmaceutical Co Ltd | Hexacyclic compounds |
US7563810B2 (en) | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
CZ299329B6 (cs) * | 2003-08-26 | 2008-06-18 | Pliva-Lachema A.S. | Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu |
CZ299593B6 (cs) * | 2003-12-16 | 2008-09-10 | Pliva-Lachema A. S. | Zpusob výroby 7-ethyl-10-hydroxykamptothecinu |
US7910593B2 (en) | 2004-04-09 | 2011-03-22 | Chugai Seiyaku Kabushiki Kaisha | Water-soluble prodrugs |
TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
JP5126900B2 (ja) * | 2009-02-24 | 2013-01-23 | 株式会社渡辺オイスター研究所 | カキ肉エキス顆粒の製造方法。 |
CN101555250B (zh) * | 2009-05-19 | 2011-05-18 | 重庆泰濠制药有限公司 | 盐酸拓扑替康的制备方法 |
KR20240031235A (ko) * | 2021-05-27 | 2024-03-07 | 자임워크스 비씨 인코포레이티드 | 캄프토테신 유사체, 접합체 및 사용 방법 |
WO2023061393A1 (zh) | 2021-10-15 | 2023-04-20 | 昆山新蕴达生物科技有限公司 | 包含抗肿瘤药物的组合物及其制备方法和用途 |
WO2023178452A1 (en) * | 2022-03-25 | 2023-09-28 | Zymeworks Bc Inc. | Antibody-drug conjugates targeting folate receptor alpha and methods of use |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399276A (en) * | 1981-01-09 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | 7-Substituted camptothecin derivatives |
JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
US5364858A (en) * | 1987-03-31 | 1994-11-15 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
US5227380A (en) * | 1987-03-31 | 1993-07-13 | Research Triangle Institute | Pharmaceutical compositions and methods employing camptothecins |
US4981968A (en) * | 1987-03-31 | 1991-01-01 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
US5180722A (en) * | 1987-04-14 | 1993-01-19 | Research Triangle Institute | 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs |
US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
NZ235329A (en) * | 1989-09-15 | 1992-01-29 | Res Triangle Inst | 20(s or rs)-camptothecin derivatives and pharmaceutical compositions |
WO1991004260A2 (en) * | 1989-09-15 | 1991-04-04 | Research Triangle Institute | 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs |
ES2137932T3 (es) * | 1990-09-28 | 2000-01-01 | Smithkline Beecham Corp | Procedimiento para la preparacion de analogos de camptotecina solubles en agua, asi como los compuestos 10-hidroxi-11-alcoxi-6-camptotecina. |
US5162532A (en) * | 1990-12-20 | 1992-11-10 | North Carolina State University | Intermediates and method of making camptothecin and camptothecin analogs |
US5342947A (en) * | 1992-10-09 | 1994-08-30 | Glaxo Inc. | Preparation of water soluble camptothecin derivatives |
GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
-
1994
- 1994-02-16 GB GB9402934A patent/GB9402934D0/en active Pending
-
1995
- 1995-02-03 AT AT95908901T patent/ATE220681T1/de active
- 1995-02-03 AU AU17056/95A patent/AU681941B2/en not_active Ceased
- 1995-02-03 MX MX9504287A patent/MX9504287A/es unknown
- 1995-02-03 JP JP7521541A patent/JPH08509244A/ja not_active Ceased
- 1995-02-03 WO PCT/EP1995/000393 patent/WO1995022549A1/en active IP Right Grant
- 1995-02-03 CA CA002158855A patent/CA2158855C/en not_active Expired - Fee Related
- 1995-02-03 NZ NZ279813A patent/NZ279813A/en unknown
- 1995-02-03 ES ES95908901T patent/ES2180625T3/es not_active Expired - Lifetime
- 1995-02-03 KR KR1019950704455A patent/KR960701878A/ko not_active Application Discontinuation
- 1995-02-03 HU HU9503273A patent/HUT73423A/hu unknown
- 1995-02-03 DE DE69527400T patent/DE69527400T2/de not_active Expired - Fee Related
- 1995-02-03 PL PL95311122A patent/PL311122A1/xx unknown
- 1995-02-03 CN CN95190093A patent/CN1123548A/zh active Pending
- 1995-02-03 EP EP95908901A patent/EP0694035B1/de not_active Expired - Lifetime
- 1995-02-13 IL IL112622A patent/IL112622A/xx not_active IP Right Cessation
- 1995-02-15 ZA ZA951227A patent/ZA951227B/xx unknown
- 1995-02-15 US US08/389,190 patent/US5602141A/en not_active Expired - Fee Related
- 1995-10-13 NO NO954072A patent/NO954072L/no unknown
- 1995-10-13 FI FI954898A patent/FI954898A0/fi not_active Application Discontinuation
-
1996
- 1996-08-20 US US08/697,125 patent/US5801167A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU1705695A (en) | 1995-09-04 |
KR960701878A (ko) | 1996-03-28 |
IL112622A0 (en) | 1995-05-26 |
WO1995022549A1 (en) | 1995-08-24 |
CA2158855A1 (en) | 1995-08-24 |
US5801167A (en) | 1998-09-01 |
GB9402934D0 (en) | 1994-04-06 |
ZA951227B (en) | 1996-01-19 |
HUT73423A (en) | 1996-07-29 |
PL311122A1 (en) | 1996-02-05 |
JPH08509244A (ja) | 1996-10-01 |
MX9504287A (es) | 1997-05-31 |
CA2158855C (en) | 2006-01-31 |
ES2180625T3 (es) | 2003-02-16 |
US5602141A (en) | 1997-02-11 |
NO954072L (no) | 1995-12-11 |
EP0694035B1 (de) | 2002-07-17 |
AU681941B2 (en) | 1997-09-11 |
EP0694035A1 (de) | 1996-01-31 |
FI954898A (fi) | 1995-10-13 |
CN1123548A (zh) | 1996-05-29 |
FI954898A0 (fi) | 1995-10-13 |
IL112622A (en) | 1997-09-30 |
DE69527400T2 (de) | 2003-03-06 |
NO954072D0 (no) | 1995-10-13 |
NZ279813A (en) | 1996-10-28 |
HU9503273D0 (en) | 1996-01-29 |
ATE220681T1 (de) | 2002-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69527400D1 (de) | Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel | |
ATE36699T1 (de) | Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung. | |
BG100946A (en) | New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them | |
ATE22889T1 (de) | 8-chlor-1,5-benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen. | |
IL123293A (en) | Piperidine derivatives, their preparation and pharmaceutical compositions containing them | |
DE59309867D1 (de) | Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
DE3576690D1 (de) | Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als anti-allergische mittel. | |
YU13396A (sh) | N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima | |
ATE156818T1 (de) | Polyfluoralkylthiopoly(ethylimidazolium)- verbindungen, verfahren zu ihrer herstellung und ihre verwendung als biozide mittel | |
UA35607C2 (uk) | Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання | |
TR199801039T2 (xx) | Yeni fenilamidin t�revlerinin elde edilmesine y�nelik usul. | |
ATE206135T1 (de) | Aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
EP0186023A3 (de) | Gallensäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten | |
ATE172976T1 (de) | 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE121396T1 (de) | Dibenzo(1,5)dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung. | |
BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
ATE287895T1 (de) | Substituierte tetrahydropyranderivate sowie verfahren zu deren herstellung | |
ATE338054T1 (de) | 17alpha-fluoralkylsteroide, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
ATE166876T1 (de) | 5,6-dihydro-4h-imidazo(4,5,1-ij)chinoline, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, und zwischenprodukte | |
ATE501158T1 (de) | Neue 2-halogen-derivate von 5-o- desosaminylerythronolid a, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
HUP0004177A2 (hu) | 4,5-Diaril-oxazol származékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
ATE195529T1 (de) | 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung | |
ATE54920T1 (de) | 2,3-diamino-2,3-didesoxyhexose-derivate, verfahren zu ihrer herstellung und ihre verwendung. | |
ATE55768T1 (de) | Substituierte alkylamino-derivate von 6,11dihydro-11-oxo-dibenz(b,e)-oxepin, verfahren zu ihrer herstellung, ihre zwischenprodukte und ihre verwendung als arzneimittel. | |
IE812957L (en) | Tricyclic compuonds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |